Secoo Holding Limited (SECO) Reaches $11.20 After 3.00% Down Move; Adverum Biotechnologies (ADVM) Shorts Up By 121.57%

April 16, 2018 - By Winifred Garcia

The stock of Secoo Holding Limited (NASDAQ:SECO) is a huge mover today! The stock decreased 2.95% or $0.34 during the last trading session, reaching $11.2. About 57,172 shares traded. Secoo Holding Limited (NASDAQ:SECO) has 0.00% since April 16, 2017 and is . It has underperformed by 11.55% the S&P500.The move comes after 5 months negative chart setup for the $566.27 million company. It was reported on Apr, 16 by Barchart.com. We have $10.86 PT which if reached, will make NASDAQ:SECO worth $16.99 million less.

Adverum Biotechnologies Inc (NASDAQ:ADVM) had an increase of 121.57% in short interest. ADVM’s SI was 1.05 million shares in April as released by FINRA. Its up 121.57% from 474,700 shares previously. With 2.13M avg volume, 1 days are for Adverum Biotechnologies Inc (NASDAQ:ADVM)’s short sellers to cover ADVM’s short positions. The SI to Adverum Biotechnologies Inc’s float is 4.32%. The stock decreased 0.39% or $0.025 during the last trading session, reaching $6.425. About 110,211 shares traded. Adverum Biotechnologies, Inc. (NASDAQ:ADVM) has risen 103.64% since April 16, 2017 and is uptrending. It has outperformed by 92.09% the S&P500.

Adverum Biotechnologies, Inc., a gene therapy company, discovers and develops novel medicines for patients suffering from rare diseases or diseases of eye. The company has market cap of $399.46 million. The firm has a pipeline that includes product candidates to treat wet age-related macular degeneration , alpha 1 antitrypsin deficiency (A1AT), and hereditary angioedema. It currently has negative earnings. The Company’s lead gene therapy programs include ADVM-022 and ADVM-032, which are in the preclinical development of new anti-VEGF gene therapy candidates for wAMD diseases; and ADVM-043, which is in patient enrollment in a phase 1/2 trial for the treatment of A1AT.

Secoo Holding Limited, through its subsidiaries, operates as an integrated online and offline shopping platform in the People's Republic of China and internationally. The company has market cap of $566.27 million. The firm provides upscale brand services and products, including bags, watches, womenÂ’s and menÂ’s wear, footwear, childrenÂ’s wear, sportswear, cosmetics and skin care products, jewelry, accessories, automobiles, home goods, find food and beverage products, arts, and Chinese original products, as well as lifestyle services through its Website, mobile applications, and offline experience centers. It currently has negative earnings. It also offers its Website as a marketplace to third party merchants to facilitate their sales of upscale services and products.

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>